Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.

Global Urology Imaging Systems Market OverviewThe global urology imaging systems market is expected to register steady growth ...

Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

Performed in a single session without any surgical incisions or scarring, the treatment utilizes an advanced fusion-guided ...

CAMC Urology recently performed his 100th robotic high intensity focused ultrasound (HIFU) procedure, an advanced treatment for patients with prostate cancer.

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

The average age of men who get diagnosed is 67.

DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of ...

The company's platform integrates genomic sequencing, clinical data analytics, and AI-driven insights across oncology, cardiology, and neuropsychiatry. Tempus serves more than 50% of U.S. oncologists ...